Premium
Mortality after radical prostatectomy in a matched contemporary cohort in Sweden compared to the Scandinavian Prostate Cancer Group 4 ( SPCG ‐4) study
Author(s) -
Cazzaniga Walter,
Garmo Hans,
Robinson David,
Holmberg Lars,
BillAxelson Anna,
Stattin Pär
Publication year - 2019
Publication title -
bju international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.773
H-Index - 148
eISSN - 1464-410X
pISSN - 1464-4096
DOI - 10.1111/bju.14563
Subject(s) - medicine , prostate cancer , hazard ratio , prostatectomy , propensity score matching , proportional hazards model , confidence interval , prostate , cohort study , cohort , gynecology , cancer , urology , oncology
Objective To investigate if results in terms of absolute risk in mature randomised trials are relevant for contemporary decision‐making. To do so, we compared the outcome for men in the radical prostatectomy ( RP ) arm of the Scandinavian Prostate Cancer Group Study number 4 ( SPCG ‐4) randomised trial with matched men treated in a contemporary era before and after compensation for the grade migration and grade inflation that have occurred since the 1980s. Patients and methods A propensity score‐matched analysis of prostate cancer mortality and all‐cause mortality in the SPCG ‐4 and matched men in the National Prostate Cancer Register ( NPCR ) of Sweden treated in 1998–2006 was conducted. Cumulative incidence of prostate cancer mortality and all‐cause mortality was calculated. Cox proportional hazards regression analyses were used to estimate hazard ratios ( HR ) and 95% confidence intervals ( CIs ) for a matching on original Gleason Grade Groups ( GGG ) and second, matching with GGG increased one unit for men in the NPCR . Results Matched men in the NPCR treated in 2005–2006 had half the risk of prostate cancer mortality compared to men in the SPCG ‐4 ( HR 0.46, 95% CI 0.19–1.14). In analysis of men matched on an upgraded GGG in the NPCR , this difference was mitigated ( HR 0.73, 95% CI 0.36–1.47). Conclusions Outcomes after RP for men in the SPCG ‐4 cannot be directly applied to men in the current era, mainly due to grade inflation and grade migration. However, by compensating for changes in grading, similar outcomes after RP were seen in the SPCG ‐4 and NPCR . In order to compare historical trials with current treatments, data on temporal changes in detection, diagnostics, and treatment have to be accounted for.